Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver
Condition: Eye and Orbit Interventions: Biological: Ipilimumab; Biological: Nivolumab; Drug: Embolization Therapy Sponsors: Sidney Kimmel Cancer Center at Thomas Jefferson University; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Liver | Melanoma | Skin Cancer | Urology & Nephrology | Uveal Melanoma | Yervoy